Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Capital Expenditures

EMERGENT BIOSOLUTIONS INC. (EBS) reported Capital Expenditures of $4.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.10M, a 27.59% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.40M, a 33.33% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $3.90M, a 129.41% increase year-over-year.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $3.40M, a 41.38% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $13.80M, a 39.74% decline from fiscal 2024.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $22.90M, a 55.62% decline from fiscal 2023.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $51.60M, a 55.44% decline from fiscal 2022.
  • EMERGENT BIOSOLUTIONS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $115.80M, a 48.33% decline from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filed
2026-06-30$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$4.50M
10-Q · filed 2026-08-06
$8.40M
derived: sum of 3 quarters · filed 2026-08-06
$11.80M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.40M
10-Q · filed 2026-05-01
$6.30M
derived: sum of 2 quarters · filed 2026-05-01
$9.70M
derived: sum of 3 quarters · filed 2026-05-01
$12.60M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$3.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$7.30M
derived: sum of 2 quarters · filed 2026-02-27
$10.20M
derived: sum of 3 quarters · filed 2026-08-06
$13.80M
10-K · filed 2026-02-27
2025-09-30$3.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$6.30M
derived: sum of 2 quarters · filed 2026-08-06
$9.90M
10-Q · filed 2025-10-30
$11.60M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$2.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.50M
10-Q · filed 2026-08-06
$8.20M
derived: sum of 3 quarters · filed 2026-08-06
$14.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$3.60M
10-Q · filed 2026-05-01
$5.30M
derived: sum of 2 quarters · filed 2026-05-01
$11.10M
derived: sum of 3 quarters · filed 2026-05-01
$15.70M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$7.50M
derived: sum of 2 quarters · filed 2026-02-27
$12.10M
derived: sum of 3 quarters · filed 2026-02-27
$22.90M
10-K · filed 2026-02-27
2024-09-30$5.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$10.40M
derived: sum of 2 quarters · filed 2025-10-30
$21.20M
10-Q · filed 2025-10-30
$32.60M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$15.40M
10-Q · filed 2025-08-07
$26.80M
derived: sum of 3 quarters · filed 2026-02-27
$39.40M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$10.80M
10-Q · filed 2025-05-08
$22.20M
derived: sum of 2 quarters · filed 2026-02-27
$34.80M
derived: sum of 3 quarters · filed 2026-02-27
$47.30M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$11.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$24.00M
derived: sum of 2 quarters · filed 2026-02-27
$36.50M
derived: sum of 3 quarters · filed 2026-02-27
$51.60M
10-K · filed 2026-02-27
2023-09-30$12.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$25.10M
derived: sum of 2 quarters · filed 2024-11-07
$40.20M
10-Q · filed 2024-11-07
$63.80M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30$12.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$27.60M
10-Q · filed 2024-08-07
$51.20M
derived: sum of 3 quarters · filed 2025-03-04
$79.10M
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31$15.10M
10-Q · filed 2024-05-02
$38.70M
derived: sum of 2 quarters · filed 2025-03-04
$66.60M
derived: sum of 3 quarters · filed 2025-03-04
$98.70M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31$23.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$51.50M
derived: sum of 2 quarters · filed 2025-03-04
$83.60M
derived: sum of 3 quarters · filed 2025-03-04
$115.80M
10-K · filed 2025-03-04
2022-09-30$27.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$60.00M
derived: sum of 2 quarters · filed 2023-12-11
$92.20M
10-Q · filed 2023-12-11
$138.00M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$32.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$64.30M
10-Q · filed 2023-08-09
$110.10M
derived: sum of 3 quarters · filed 2024-03-08
$165.30M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$32.20M
10-Q · filed 2023-05-10
$78.00M
derived: sum of 2 quarters · filed 2024-03-08
$133.20M
derived: sum of 3 quarters · filed 2024-03-08
$200.20M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$45.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$101.00M
derived: sum of 2 quarters · filed 2024-03-08
$168.00M
derived: sum of 3 quarters · filed 2024-03-08
$224.10M
10-K · filed 2024-03-08
$225.00M
10-K · filed 2022-02-25
2021-09-30$55.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$122.20M
derived: sum of 2 quarters · filed 2022-11-09
$178.30M
10-Q · filed 2022-11-09
$215.20M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30$67.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$123.10M
10-Q · filed 2022-08-02
$160.00M
derived: sum of 3 quarters · filed 2023-12-11
$205.70M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31$56.10M
10-Q · filed 2022-04-29
$93.00M
derived: sum of 2 quarters · filed 2023-12-11
$138.70M
derived: sum of 3 quarters · filed 2023-12-11
$173.80M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31$36.90M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$82.60M
derived: sum of 2 quarters · filed 2023-12-11
$117.70M
derived: sum of 3 quarters · filed 2023-12-11
$141.90M
10-K/A · filed 2023-12-11
$141.00M
10-K · filed 2021-02-19
2020-09-30$45.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$80.80M
derived: sum of 2 quarters · filed 2021-11-05
$105.00M
10-Q · filed 2021-11-05
$141.10M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$35.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$59.30M
10-Q · filed 2021-07-30
$95.40M
derived: sum of 3 quarters · filed 2022-02-25
$110.70M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$24.20M
10-Q · filed 2021-04-30
$60.30M
derived: sum of 2 quarters · filed 2022-02-25
$75.60M
derived: sum of 3 quarters · filed 2022-02-25
$89.70M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$36.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$51.40M
derived: sum of 2 quarters · filed 2022-02-25
$65.50M
derived: sum of 3 quarters · filed 2022-02-25
$86.90M
10-K · filed 2022-02-25
2019-09-30$15.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$29.40M
derived: sum of 2 quarters · filed 2020-11-06
$50.80M
10-Q · filed 2020-11-06
$71.60M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$14.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$35.50M
10-Q · filed 2020-07-31
$56.30M
derived: sum of 3 quarters · filed 2021-02-19
$82.40M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$21.40M
10-Q · filed 2020-05-01
$42.20M
derived: sum of 2 quarters · filed 2021-02-19
$68.30M
derived: sum of 3 quarters · filed 2021-02-19
$81.90M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$20.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$46.90M
derived: sum of 2 quarters · filed 2021-02-19
$60.50M
derived: sum of 3 quarters · filed 2021-02-19
$72.10M
10-K · filed 2021-02-19
2018-09-30$26.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$39.70M
derived: sum of 2 quarters · filed 2019-11-07
$51.30M
10-Q · filed 2019-11-07
$51.27M
10-Q · filed 2018-11-02
$63.72M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$13.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$25.20M
10-Q · filed 2019-08-02
$25.22M
10-Q · filed 2018-08-03
$37.62M
derived: sum of 3 quarters · filed 2020-02-25
$50.40M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$11.60M
10-Q · filed 2019-05-08
$11.62M
10-Q · filed 2018-05-04
$24.02M
derived: sum of 2 quarters · filed 2020-02-25
$36.80M
derived: sum of 3 quarters · filed 2020-02-25
$46.10M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$12.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$25.20M
derived: sum of 2 quarters · filed 2020-02-25
$34.50M
derived: sum of 3 quarters · filed 2020-02-25
$54.80M
10-K · filed 2020-02-25
$54.83M
10-K · filed 2018-02-23
2017-09-30$12.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$22.08M
derived: sum of 2 quarters · filed 2018-11-02
$42.38M
10-Q · filed 2018-11-02
$62.34M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$9.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$29.61M
10-Q · filed 2018-08-03
$49.56M
derived: sum of 3 quarters · filed 2019-02-22
$66.56M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$20.30M
10-Q · filed 2018-05-04
$40.26M
derived: sum of 2 quarters · filed 2019-02-22
$57.26M
derived: sum of 3 quarters · filed 2019-02-22
$78.29M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$19.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$36.95M
derived: sum of 2 quarters · filed 2019-02-22
$57.99M
derived: sum of 3 quarters · filed 2019-02-22
$76.20M
10-K · filed 2019-02-22
$76.26M
10-K · filed 2017-02-28
2016-09-30$17.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$38.03M
derived: sum of 2 quarters · filed 2017-11-03
$56.24M
10-Q · filed 2017-11-03
$67.42M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$21.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$39.25M
10-Q · filed 2017-08-04
$50.43M
derived: sum of 3 quarters · filed 2018-02-23
$64.38M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$18.21M
10-Q · filed 2017-05-05
$29.39M
derived: sum of 2 quarters · filed 2018-02-23
$43.34M
derived: sum of 3 quarters · filed 2018-02-23
$53.94M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$11.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$25.13M
derived: sum of 2 quarters · filed 2018-02-23
$35.73M
derived: sum of 3 quarters · filed 2018-02-23
$44.81M
10-K · filed 2018-02-23
2015-09-30$13.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$24.55M
derived: sum of 2 quarters · filed 2016-11-09
$33.63M
10-Q · filed 2016-11-09
$49.68M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$10.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$19.68M
10-Q · filed 2016-08-05
$35.73M
derived: sum of 3 quarters · filed 2017-02-28
$40.95M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$9.08M
10-Q · filed 2016-05-06
$25.13M
derived: sum of 2 quarters · filed 2017-02-28
$30.36M
derived: sum of 3 quarters · filed 2017-02-28
$35.16M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$16.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$21.27M
derived: sum of 2 quarters · filed 2017-02-28
$26.08M
derived: sum of 3 quarters · filed 2017-02-28
$30.67M
10-K · filed 2017-02-28
2014-09-30$5.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$10.03M
derived: sum of 2 quarters · filed 2015-11-06
$14.62M
10-Q · filed 2015-11-06
$22.22M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$4.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$9.40M
10-Q · filed 2015-08-06
$17.00M
derived: sum of 3 quarters · filed 2016-02-29
$37.30M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$4.59M
10-Q · filed 2015-05-08
$12.19M
derived: sum of 2 quarters · filed 2016-02-29
$32.49M
derived: sum of 3 quarters · filed 2016-02-29
$38.93M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$7.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$27.90M
derived: sum of 2 quarters · filed 2016-02-29
$34.34M
derived: sum of 3 quarters · filed 2016-02-29
$42.02M
10-K · filed 2016-02-29
2013-09-30$20.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$26.74M
derived: sum of 2 quarters · filed 2014-11-10
$34.42M
10-Q · filed 2014-11-10
$47.32M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$6.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$14.12M
10-Q · filed 2014-08-08
$27.02M
derived: sum of 3 quarters · filed 2015-03-09
$37.05M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$7.68M
10-Q · filed 2014-05-12
$20.58M
derived: sum of 2 quarters · filed 2015-03-09
$30.60M
derived: sum of 3 quarters · filed 2015-03-09
$39.20M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$12.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$22.92M
derived: sum of 2 quarters · filed 2015-03-09
$31.52M
derived: sum of 3 quarters · filed 2015-03-09
$53.84M
10-K · filed 2015-03-09
2012-09-30$10.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$18.61M
derived: sum of 2 quarters · filed 2013-11-08
$40.94M
10-Q · filed 2013-11-08
$60.82M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$8.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$30.92M
10-Q · filed 2013-08-06
$50.79M
derived: sum of 3 quarters · filed 2014-03-10
$68.15M
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31$22.33M
10-Q · filed 2013-05-03
$42.20M
derived: sum of 2 quarters · filed 2014-03-10
$59.56M
derived: sum of 3 quarters · filed 2014-03-10
$67.92M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31$19.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$37.23M
derived: sum of 2 quarters · filed 2014-03-10
$45.59M
derived: sum of 3 quarters · filed 2014-03-10
$54.03M
10-K · filed 2014-03-10
2011-09-30$17.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$25.72M
derived: sum of 2 quarters · filed 2012-11-01
$34.15M
10-Q · filed 2012-11-01
$42.21M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30$8.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$16.80M
10-Q · filed 2012-08-03
$24.85M
derived: sum of 3 quarters · filed 2013-03-08
$30.27M
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31$8.43M
10-Q · filed 2012-05-04
$16.49M
derived: sum of 2 quarters · filed 2013-03-08
$21.90M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$8.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$13.47M
derived: sum of 2 quarters · filed 2013-03-08
$22.10M
10-K · filed 2013-03-08
2010-09-30$5.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$14.04M
10-Q · filed 2011-11-04
2010-06-30$8.63M
10-Q · filed 2011-08-05
2009-12-31$33.29M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45